News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Gipson_Shih_YeeMarie_Tan_BOS_web.jpg)
An update on the pharmacologic treatment of hypersomnia
- Author:
- Shih Yee-Marie Tan Gipson, MD
- Kevin Gipson, MD
Publish date: August 25, 2020
Hypersomnolence may be severely disabling for patients and is associated with decreased quality of life and economic disadvantage.